Retinoic acid for treatment of multicentric Castleman's disease

Lancet

Volumn 354, Issue 9186, 1999, Pages 1262-1263

  Rieu, Philippe ^a   Droz, Dominique ^a   Gessain, Antoine ^b   Grünfeld, Jean Pierre ^a   Hermine, Olivier ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PREDNISONE; RETINOIC ACID;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; DISEASE COURSE; EDEMA; FEMALE; FEVER; HUMAN; HYPERTENSION; KIDNEY DISEASE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; WEIGHT GAIN;

EID: 0033539315     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03957-4     Document Type: Article

References (5)

1. Nagpal S Cai J, Zheng T et al. Retinoid antagonisms of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 17:1997;159-168.
2. Authier F.J., Belec L., Levy Y.et al. All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines. Arth Rheum. 39:1996;1423-1426.
3. Raife T.J., McArthur J., Peters C., Kisker C.T., Lentz S.R. Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura. Lancet. 352:1998;454-455.
4. Karpman D., Andreasson A., Thysell H., Kaplan B.S., Svanborg C. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Ped Nephrol. 9:1995;694-699.
5. Beck J.T., Hsu S.M., Wijdenes J.et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukine-6 antibody. N Engl J Med. 330:1994;602-605.